Replimune Group Inc’s recently made public that its Chief Medical Officer Xynos Konstantinos unloaded Company’s shares for reported $78112.0 on Nov 18 ’24. In the deal valued at $10.78 per share,7,246 shares were sold. As a result of this transaction, Xynos Konstantinos now holds 109,885 shares worth roughly $1.38 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Sarchi Christopher sold 5,207 shares, generating $56,131 in total proceeds. Upon selling the shares at $10.78, the Chief Commercial Officer now owns 87,045 shares.
Before that, Hill Emily Luisa sold 8,938 shares. Replimune Group Inc shares valued at $90,989 were divested by the Chief Financial Officer at a price of $10.18 per share. As a result of the transaction, Hill Emily Luisa now holds 101,057 shares, worth roughly $1.27 million.
ROTH MKM initiated its Replimune Group Inc [REPL] rating to a Buy in a research note published on August 28, 2024; the price target was $17. Piper Sandler began covering REPL with “an Overweight” recommendation on November 19, 2021.
Price Performance Review of REPL
On Friday, Replimune Group Inc [NASDAQ:REPL] saw its stock jump 2.70% to $12.55. Over the last five days, the stock has lost -4.05%. Replimune Group Inc shares have risen nearly 48.87% since the year began. Nevertheless, the stocks have risen 61.52% over the past one year. While a 52-week high of $17.00 was reached on 11/22/24, a 52-week low of $4.92 was recorded on 05/29/24. SMA at 50 days reached $12.14, while 200 days put it at $9.51.
Levels Of Support And Resistance For REPL Stock
The 24-hour chart illustrates a support level at 12.15, which if violated will result in even more drops to 11.75. On the upside, there is a resistance level at 12.80. A further resistance level may holdings at 13.05. The Relative Strength Index (RSI) on the 14-day chart is 49.59, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.72, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.37%. Stochastics %K at 15.54% indicates the stock is a buying.
How much short interest is there in Replimune Group Inc?
A steep rise in short interest was recorded in Replimune Group Inc stocks on 2024-11-29, dropping by -1.47 million shares to a total of 5.58 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 7.05 million shares. There was a decline of -26.26%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 17, 2020 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $60 price target.
